Community actions
-
Holding
-
Recently bought
-
Recently sold
Halozyme Therapeutics, Inc. news
-
Halozyme Therapeutics Stock Earns IBD Stock Rating Upgrade, Hitting 80-Plus RS Rating
-
Here's Why Halozyme Therapeutics (HALO) is a Strong Growth Stock
-
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
-
Biotech Stocks To Watch: Halozyme Actionable Now After Earnings-Fueled Breakout
-
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2024 Earnings Call Transcript
-
Halozyme Therapeutics Inc (HALO) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth ...
-
Halozyme Therapeutics (HALO) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
-
Halozyme Therapeutics Q1 2024 Earnings: Misses EPS Estimates but Shows Revenue Growth
Recent Motivations